Zingerone suppresses angiogenesis via inhibition of matrix metalloproteinases during tumor development

Oncotarget. 2016 Jul 26;7(30):47232-47241. doi: 10.18632/oncotarget.10030.

Abstract

Angiogenesis is an essential step for tumor survival and progression, and the inhibition of angiogenesis is a good strategy for tumor therapeutics. In this study, we investigated the therapeutic effect of zingerone in a mouse tumor model. Zingerone suppressed tumor progression and tumor angiogenesis. Moreover, we found that zingerone inhibited the angiogenic activities of endothelial cells by both direct and indirect means. A mechanistic study showed that the activities of MMP-2 and MMP-9 in tumor cells were decreased by treatment with zingerone. Interestingly, zingerone-mediated inhibition of MMP-2 and MMP-9 was involved in the JNK pathway. In conclusion, zingerone showed strong anti-angiogenic activity via the inhibition of MMP-2 and MMP-9 during tumor progression, suggesting that zingerone may be a potential therapeutic drug for human cancers.

Keywords: JNK; angiogenesis; cancer; matrix metalloproteinases; zingerone.

MeSH terms

  • Animals
  • Cell Growth Processes / drug effects
  • Disease Models, Animal
  • Guaiacol / analogs & derivatives*
  • Guaiacol / pharmacology
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
  • Kidney Neoplasms / blood supply*
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / enzymology
  • Male
  • Matrix Metalloproteinase 2 / metabolism
  • Matrix Metalloproteinase 9 / metabolism
  • Matrix Metalloproteinase Inhibitors / pharmacology*
  • Mice
  • Mice, Inbred BALB C
  • Neovascularization, Pathologic / drug therapy
  • Neovascularization, Pathologic / enzymology

Substances

  • Hif1a protein, mouse
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Matrix Metalloproteinase Inhibitors
  • zingerone
  • Guaiacol
  • Matrix Metalloproteinase 2
  • Mmp2 protein, mouse
  • Matrix Metalloproteinase 9
  • Mmp9 protein, mouse